“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.
“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.